Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancerNeill Patani, Anita K Dunbier, Helen Anderson, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2007
A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancerTeresa Guerrero Urbano, Catharine H Clark, Vibeke N Hansen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039)Alexandra Leary, Abigail Evans, Stephen R D Johnston, et al.The Journal of Pathology|January 19, 2012
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selectionLucia Hernandez, Paul M Wilkerson, Maryou B Lambros, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal womenAnita K Dunbier, Helen Anderson, Zara Ghazoui, et al.International Journal of Radiation Oncology, Biology, Physics|January 18, 2011
Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancersAisha B Miah, Shreerang A Bhide, M Teresa Guerrero-Urbano, et al.The Journal of Pathology|October 26, 2011
Immunophenotypic and genomic characterization of papillary carcinomas of the breastRaphaëlle Duprez, Paul M Wilkerson, Magali Lacroix-Triki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancerCatherine L Harper-Wynne, Nigel P M Sacks, Karyn Shenton, et al.The Journal of Pathology|October 22, 2011
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancersDaniel Wetterskog, Maria Angeles Lopez-Garcia, Maryou B Lambros, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancerGerhardt Attard, Alison H M Reid, Roger A'Hern, et al.Pageof 8